https://researchportal.murdoch.edu.au/esploro/outputs/journalArticle/NMOSD-and-MS-prevalence-in-the/991005540219507891?institution=61MUN_INST&skipUsageReporting=true&recordUsage=false
NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand - Murdoch...
Background We studied the prevalence of neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS) in Indigenous populations of Australia and...
australia new zealandindigenous populationsnmosdmsprevalence
https://neuromyelitis-optica.net/living/nmo-vision-loss
NMOSD & Vision Loss: Coping with Changes to Daily Life
NMOSD can steal more than just sight. Monica Jones shares her personal journey with vision loss, losing her independence, and the emotional toll of "the...
vision lossdaily lifenmosdcopingchanges
https://nmosd.com/
Navigating NMOSD | Patient education site
Learn about neuromyelitis optica spectrum disorder (NMOSD) causes, diagnosis, symptoms, testing, and treatment.
patient educationnavigatingnmosdsite
https://myneuronews.com/dissecting-nmosd-pathogenesis-through-animal-models-a-mechanism-oriented-systems-perspective/
Dissecting NMOSD pathogenesis through animal models: a mechanism-oriented systems perspective |
May 6, 2026 - Mechanistic Insights into NMOSDNeuromyelitis Optica Spectrum Disorder (NMOSD) is a complex autoimmune condition that primarily affects the central nervous
animal modelsnmosdpathogenesismechanismoriented
https://medically.roche.com/au/en/neuroscience/diseases/neuromyelitis-optica-spectrum-disorder--nmosd-.html
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Learn more about novel approaches to advance the management of serious disorders and diseases specifically relating to neuromyelitis optica spectrum disorder...
neuromyelitis opticaspectrumdisordernmosd
https://pubmed.ncbi.nlm.nih.gov/31471502/
Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD
sGFAP and sNfL are likely to be good biomarkers of disease activity and disability, and the sGFAP/sNfL quotient at relapse is a potential diagnostic marker for...
serumlightbiomarkersdiseaseactivity
https://ectrims.eu/topic/nmosd/?pg=39
NMOSD Archives | ECTRIMS
nmosdarchivesectrims